InterVene

South San Francisco, United States

InterVene is a medical device company that treats severe venous disease in the legs.

$13.0M raised

Oct 2024

Series A

Top Investors

Correlation VenturesBoston ScientificRiverVestTreo VenturesLaunchCapital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has InterVene raised?

InterVene has raised $13.0M in total funding. The most recent round was Series A. The last funding was announced in October 2024.

Who are InterVene's investors?

InterVene's investors include Correlation Ventures, Boston Scientific, RiverVest, Treo Ventures, LaunchCapital.

Where is InterVene headquartered?

InterVene is headquartered in South San Francisco, United States.

What does InterVene do?

InterVene is a medical device company that treats severe venous disease in the legs.

What stage is InterVene at?

InterVene is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 7, 2024.

MLA

"InterVene — Funding & Investors." VCBacked, October 7, 2024, https://www.vcbacked.co/company/intervene. Accessed June 4, 2026.

APA

VCBacked. (2024). InterVene — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/intervene

Wikipedia (cite web)

{{cite web |title=InterVene — Funding & Investors |url=https://www.vcbacked.co/company/intervene |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 7, 2024.